Table 2.

Prevalence and associated factors of metabolic syndrome in HIV+ women (n = 273, bivariate analysis).

Variables	MetS+ (%)	MetS− (%)	pa
Age (years)			0.002
40–49	39.3	60.7
50–60	60.2	39.8
Skin color			0.763
Other	48.0	52.0
White	45.3	54.7
Physical activityc			1.000
0–2 times/week	46.5	53.5
≥3 times/week	47.3	52.7
Formal education (years)			0.003
0–7	55.0	45.0
≥8	35.2	64.8
Smoking			0.722
No/past	45.9	54.1
Yes	49.3	50.7
Alcohol consumption			0.842
No/past	47.5	52.5
Yes	45.2	54.8
Menopausal status			<0.001
Pre- or peri-menopause	37.3	62.7
Post-menopause	61.2	38.8
Weight gainc			0.075
No	41.7	58.3
Yes	53.8	46.2
Hormonal therapyd			0.189b
No	46.2	53.8
Yes	80.0	20.0
Self-perception of healthd			0.861
Excellent/good	47.6	52.4
Not so good/bad	45.6	54.4
On ART			0.318
No	34.8	65.2
Yes	48.1	51.9
Other chronic diseasese			0.596
No	44.3	55.7
Yes	48.8	51.2
BMI (kg/m2)c			<0.001
≤25	28.7	71.3
>25	68.1	31.9
FSH (mIU/mL)f			0.002
<40	37.2	62.8
≥40	58.7	41.3
Illicit drugs use			0.311
No	48.4	51.6
Yes/past	37.8	62.2
Time since HIV diagnosis (years)h			0.681
0–10	48.0	52.0
>10	44.4	55.6
ART duration (years)i			0.053
0–1	10.0	90.0
≥2	46.5	53.5
Current HIV-1 RNA PCR (copies/mL)g			0.742
0–50	45.5	54.5
>50	49.1	50.9
Current CD4 cell count (cells/mm3)j			0.212
0–199	63.2	36.8
≥200	45.5	54.5
Lopinavir use (previous or current)k			0.355
Yes	42.3	57.7
No	50.0	50.0
Indinavir (previous or current)l			0.127
Yes	58.1	41.9
No	43.5	56.5

^aYates chi-square.

^bFisher's exact test.

HIV, human immunodeficiency virus; BMI, body mass index; HAART, highly active antiretroviral therapy; FSH, follicle stimulating hormone.

Missing data:

^c1 case.

^d2 cases.

^e7 cases.

^f15 cases.

^g10 cases.

^h23 cases.

ⁱ61 cases.

^j6 cases.

^k52 cases.

^l59 cases.